JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koyanagi, S.
Right arrow Articles by Higuchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koyanagi, S.
Right arrow Articles by Higuchi, S.

Vol. 283, Issue 1, 259-264, 1997

Chronopharmacological Study of Interferon-alpha in Mice

Satoru Koyanagi, Shigehiro Ohdo, Eiji Yukawa and Shun Higuchi

Department of Clinical Pharmacokinetics, Division of Pharmaceutical Science, Kyushu University, Fukuoka, Japan

The influence of dosing time on the pharmacological effects (fever and antiviral activity) and the pharmacokinetics of interferon-alpha (IFN-alpha ) was investigated in ICR male mice under light-dark (12:12) cycle. There was a significant circadian rhythm in rectal temperature, as an index of fever, at 0.5 hr after IFN-alpha (10.0 MIU/kg i.v.) injection. The rhythmic pattern resembled overall the rhythm that occurs in the nondrugged state. However, the percent change from basal level of rectal temperature varied according to the dosing time. The rhythmicity corresponded to the dosing time-dependent difference of PGE2 levels in thalamus after IFN-alpha injection, but it did not correspond to that of plasma IFN-alpha concentrations. A significant dosing time-dependent difference was also demonstrated for 2'-5'oligoadenylate synthetase activities, as an index of antiviral activity, in plasma and liver at 24 hr after IFN-alpha injection. It was related to the rhythmicity in plasma IFN-alpha concentrations that was caused by the rhythmicity in clearance of IFN-alpha . The choice of the most appropriate time of day for drug administration may help to achieve rational chronotherapeutics of IFN-alpha in certain experimental and clinical situations.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Koyanagi, H. Suyama, Y. Kuramoto, N. Matsunaga, H. Takane, S. Soeda, H. Shimeno, S. Higuchi, and S. Ohdo
Glucocorticoid Regulation of 24-Hour Oscillation in Interferon Receptor Gene Expression in Mouse Liver
Endocrinology, November 1, 2006; 147(11): 5034 - 5040.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Koyanagi, Y. Kuramoto, H. Nakagawa, H. Aramaki, S. Ohdo, S. Soeda, and H. Shimeno
A Molecular Mechanism Regulating Circadian Expression of Vascular Endothelial Growth Factor in Tumor Cells
Cancer Res., November 1, 2003; 63(21): 7277 - 7283.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Koyanagi, H. Nakagawa, Y. Kuramoto, S. Ohdo, S. Soeda, and H. Shimeno
Optimizing the Dosing Schedule of TNP-470 [O-(Chloroacetyl-carbamoyl) Fumagillol] Enhances Its Antitumor and Antiangiogenic Efficacies
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 669 - 674.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Pan, T. Terada, M. Irie, H. Saito, and K.-I. Inui
Diurnal rhythm of H+-peptide cotransporter in rat small intestine
Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G57 - G64.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Viyoch, S. Ohdo, E. Yukawa, and S. Higuchi
Dosing Time-Dependent Tolerance of Catalepsy by Repetitive Administration of Haloperidol in Mice
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 964 - 969.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
D.-s. Wang, S. Ohdo, S. Koyanagi, H. Takane, H. Aramaki, E. Yukawa, and S. Higuchi
Effect of Dosing Schedule on Pharmacokinetics of Alpha Interferon and Anti-Alpha Interferon Neutralizing Antibody in Mice
Antimicrob. Agents Chemother., January 1, 2001; 45(1): 176 - 180.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ohdo, D.-S. Wang, S. Koyanagi, H. Takane, K. Inoue, H. Aramaki, E. Yukawa, and S. Higuchi
Basis for Dosing Time-Dependent Changes in the Antiviral Activity of Interferon-alpha in Mice
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 488 - 493.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Takane, S. Ohdo, T. Yamada, E. Yukawa, and S. Higuchi
Chronopharmacology of Antitumor Effect Induced by Interferon-beta in Tumor-Bearing Mice
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 746 - 752.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.